False positive diagnosis on (131)iodine whole-body scintigraphy of differentiated thyroid cancers.

Vincenzo Triggiani, Vito Angelo Giagulli, Michele Iovino, Giovanni De Pergola, Brunella Licchelli, Antonio Varraso, Franca Dicembrino, Guido Valle, Edoardo Guastamacchia

Journal: Endocrine 2017;53(3):626-35

PMID: 26499192

Abstract

(131)Iodine is used both to ablate any residual thyroid tissue or metastatic disease and to obtain whole-body diagnostic images after total thyroidectomy for differentiated thyroid cancer (DTC). Even though whole-body scan is highly accurate in showing thyroid residues as well as metastases of DTC, false positive results can be found, possibly leading to diagnostic errors and unnecessary treatments. This paper reviews the physiological and pathological processes involved as well as the strategy to recognize and rule out false positive radioiodine images.

Address: Interdisciplinary Department of Medicine. Endocrinology and Metabolic Diseases, University of Bari, Bari, Italy. [email protected].; Interdisciplinary Department of Medicine. Endocrinology and Metabolic Diseases, University of Bari, Bari, Italy.; Endocrinology and Metabolic Diseases, Eboli Hospital, Eboli, Salerno, Italy.; Oncology Unit, University of Bari, Bari, Italy.; Nuclear Medicine, IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Foggia, Italy.

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.